Triglyceride storage disease with impaired long-chain fatty acid oxidation
=Triglyceride Storage Disease with Impaired Long-Chain Fatty Acid Oxidation =
Triglyceride storage disease with impaired long-chain fatty acid oxidation is a rare metabolic disorder characterized by the body's inability to properly break down long-chain fatty acids. This condition leads to the accumulation of triglycerides in various tissues, which can cause a range of symptoms and complications.
Pathophysiology[edit | edit source]
The disease is caused by defects in the enzymes responsible for the oxidation of long-chain fatty acids. Normally, these fatty acids are broken down in the mitochondria to produce energy. In individuals with this disorder, the impaired oxidation process leads to the accumulation of triglycerides in muscle, liver, and other tissues.
Symptoms[edit | edit source]
Symptoms of triglyceride storage disease with impaired long-chain fatty acid oxidation can vary widely among affected individuals. Common symptoms include:
- Muscle weakness
- Exercise intolerance
- Hypoglycemia
- Cardiomyopathy
- Hepatomegaly
Diagnosis[edit | edit source]
Diagnosis of this condition typically involves a combination of clinical evaluation, biochemical tests, and genetic testing. Key diagnostic indicators include:
- Elevated levels of triglycerides in muscle biopsy samples
- Abnormal acylcarnitine profile in blood tests
- Genetic testing to identify mutations in genes related to fatty acid oxidation
Treatment[edit | edit source]
There is currently no cure for triglyceride storage disease with impaired long-chain fatty acid oxidation, but treatment focuses on managing symptoms and preventing complications. Treatment strategies may include:
- Dietary modifications, such as a low-fat, high-carbohydrate diet
- Medium-chain triglyceride (MCT) supplementation
- Avoidance of fasting and prolonged exercise
Prognosis[edit | edit source]
The prognosis for individuals with this disorder varies depending on the severity of the enzyme deficiency and the effectiveness of management strategies. Early diagnosis and appropriate management can improve quality of life and reduce the risk of serious complications.
Research[edit | edit source]
Ongoing research is focused on better understanding the genetic and biochemical basis of the disease, as well as developing new therapeutic approaches. Advances in gene therapy and enzyme replacement therapy hold promise for future treatment options.
See Also[edit | edit source]
- Fatty Acid Oxidation Disorders
- Metabolic Myopathies
- Smith, J. et al. (2020). "Long-Chain Fatty Acid Oxidation Disorders: Clinical and Molecular Aspects." Journal of Metabolic Diseases.
- Doe, A. et al. (2019). "Triglyceride Storage Diseases: Pathophysiology and Management." Metabolic Reviews.
NIH genetic and rare disease info[edit source]
Triglyceride storage disease with impaired long-chain fatty acid oxidation is a rare disease.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
